Abstract: A method of monitoring synthetic gas emissions comprises obtaining a gas concentration image within a first area of interest from an overhead image acquisition device, detecting from the gas concentration image at least one gas plume of a synthetic gas emission, quantifying an emission rate of the detected gas plume, estimating an estimated point source of the detected gas plume, and attributing the detecting gas plume to an actual point source. A corresponding system for monitoring synthetic gas emissions comprises a memory storing a gas concentration image of a first area of interest, and a processor communicatively coupled thereto and configured to detect from the image of the gas concentration at least one gas plume of a synthetic gas emission, quantify an emission rate of the detected gas plume, estimate an estimated point source of the detected gas plume, and attribute the detecting gas plume to an actual point source.

Abstract: The present invention relates to the combined use of bezafibrate and of resveratrol or resveratrol derivatives for the treatment of diseases involving a mitochondrial energy dysfunction, and also to a pharmaceutical kit comprising both bezafibrate and resveratrol or resveratrol derivatives. The combination is more particularly used in the treatment of moderate defects of ?-oxidation of long-chain fatty acids or of the respiratory chain of mitochondria.

Abstract: The present invention relates to the combined use of bezafibrate and of resveratrol or resveratrol derivatives for the treatment of diseases involving a mitochondrial energy dysfunction, and also to a pharmaceutical kit comprising both bezafibrate and resveratrol or resveratrol derivatives. The combination is more particularly used in the treatment of moderate defects of ?-oxidation of long-chain fatty acids or of the respiratory chain of mitochondria.